FindTrial
Sign In

Different Approaches for the Management of Post-dural Puncture Headache

Comparative Study Between Different Approaches for the Management of Post-dural Puncture Headache

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05253014
Enrollment
120
Registered
2022-02-23
Start date
2018-01-01
Completion date
2020-12-30
Last updated
2022-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Dural Puncture Headache

Brief summary

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

Interventions

PROCEDUREsphenopalatine ganglion block

block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache

DRUGparacetamol

intravenous paracetamol every 8 hours

Sponsors

Bahaa Mohammed Refaie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* The ASA physical condition І-П * the patient underwent CS under spinal anesthesia * The headache developed within 5 days after the dural puncture * There is no different explanation for the headache

Exclusion criteria

* coagulopathy * history of nasal bleeding * nasal polyp * septal deviation * local anesthetics reaction

Design outcomes

Primary

MeasureTime frameDescription
postdural puncture headachewithin five days after the dural puncturevisual analog scale

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026